PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | Rociletinib | C27H28F3N7O3

Rociletinib

  • Molecular FormulaC27H28F3N7O3
  • Average mass555.552 Da
  • Monoisotopic mass555.220581 Da
  • ChemSpider ID30646712

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

. N-(3-{[2-{[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5- (trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide
1374640-70-6 [RN]
2-Propenamide, N-[3-[[2-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]- [ACD/Index Name]
72AH61702G
9986
CO 1686
CO-1686
N-(3-{[2-{[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino}-5-(trifluormethyl)-4-pyrimidinyl]amino}phenyl)acrylamid [German] [ACD/IUPAC Name]
N-(3-{[2-{[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)-4-pyrimidinyl]amino}phenyl)acrylamide [ACD/IUPAC Name]
N-(3-{[2-{[4-(4-Acétyl-1-pipérazinyl)-2-méthoxyphényl]amino}-5-(trifluorométhyl)-4-pyrimidinyl]amino}phényl)acrylamide [French] [ACD/IUPAC Name]
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Target Organs:

      EGFR inhibitor TargetMol T2369
    • Bio Activity:

      CO-1686 is a novel, irreversible and orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M(IC50=21 nM). MedChem Express http://www.medchemexpress.com/nu-7026.html, HY-15729
      CO-1686 is a novel, irreversible and orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M(IC50=21 nM). ;IC50 Value: 21.5?1.7 nM (EGFRL858R/T790M); 303.3 ? 26.7 nM (EGFRWT) [1];In vitro: CO-1686 is a potent inhibitor of EGFR L858R/T790M kinase (kinact/Ki = (2.41 ? 0.30) x 105 M-1s-1) and is approximately 22-fold selective over WT EGFR (kinactt/Ki = (1.12 ? 0.14) x 104 M-1s-1). CO-1686 potently inhibited proliferation in the mutant-EGFR NSCLC cellswith GI50 values ranging from 7 - 32 nM. In comparison, the GI50 value for A431 cells, an epidermoid cell line that is driven by amplified WT EGFR(19), was 547 nM. Two cell linesexpressing WT EGFR in the presence of an N- or KRAS mutation (NCI-H1299 and NCI-H358,respectively) were inhibited by CO-1686 at a concentration of 4275 and 1806 nM, respectively [1].;In vivo: CO-1686 displayed high oral bioavailability (65%) and a relatively long half-life of 2.6 hours when dosed at 20 mg/kg. Tumor MedChem Express HY-15729
      EGFR MedChem Express HY-15729
      JAK/STAT Signaling MedChem Express HY-15729
      JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; MedChem Express HY-15729
      Mutant EGFR TargetMol T2369
      Tyrosine Kinase/Adaptors TargetMol T2369

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.4±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.632
Molar Refractivity: 144.4±0.3 cm3
#H bond acceptors: 10
#H bond donors: 3
#Freely Rotating Bonds: 9
#Rule of 5 Violations: 2
ACD/LogP: 2.38
ACD/LogD (pH 5.5): 3.06
ACD/BCF (pH 5.5): 122.35
ACD/KOC (pH 5.5): 1073.98
ACD/LogD (pH 7.4): 3.07
ACD/BCF (pH 7.4): 127.25
ACD/KOC (pH 7.4): 1116.99
Polar Surface Area: 112 Å2
Polarizability: 57.3±0.5 10-24cm3
Surface Tension: 59.8±3.0 dyne/cm
Molar Volume: 404.7±3.0 cm3

Click to predict properties on the Chemicalize site






Advertisement